VALIANT LABORATORIES
|
VALIANT LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
EQUITY AND LIABILITIES | ||
Share Capital | ₹43 Cr | ₹33 Cr |
Equity - Authorised | ₹45 Cr | ₹45 Cr |
Equity - Issued | ₹43 Cr | ₹33 Cr |
Equity Paid Up | ₹43 Cr | ₹33 Cr |
Equity Shares Forfeited | - | - |
Adjustments to Equity | - | - |
Preference Capital Paid Up | - | - |
Face Value | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - |
Total Reserves | ₹193 Cr | ₹68 Cr |
Securities Premium | ₹141 Cr | ₹16 Cr |
Capital Reserves | - | - |
Profit & Loss Account Balance | ₹52 Cr | ₹52 Cr |
General Reserves | - | - |
Other Reserves | - | - |
Reserve excluding Revaluation Reserve | ₹193 Cr | ₹68 Cr |
Revaluation reserve | - | - |
Shareholder's Funds | ₹237 Cr | ₹100 Cr |
Minority Interest | - | - |
Long-Term Borrowings | - | - |
Secured Loans | ₹15 Cr | - |
Non Convertible Debentures | - | - |
Converible Debentures & Bonds | - | - |
Packing Credit - Bank | - | - |
Inter Corporate & Security Deposit | - | - |
Term Loans - Banks | ₹15 Cr | - |
Term Loans - Institutions | - | - |
Other Secured | - | - |
Unsecured Loans | ₹59 Cr | ₹59 Cr |
Fixed Deposits - Public | - | - |
Loans and advances from subsidiaries | - | - |
Inter Corporate Deposits (Unsecured) | - | - |
Foreign Currency Convertible Notes | - | - |
Long Term Loan in Foreign Currency | - | - |
Loans - Banks | - | - |
Loans - Govt. | - | - |
Loans - Others | ₹59 Cr | ₹59 Cr |
Other Unsecured Loan | - | - |
Deferred Tax Assets / Liabilities | ₹0.62 Cr | ₹0.67 Cr |
Deferred Tax Assets | ₹0.68 Cr | ₹0.52 Cr |
Deferred Tax Liability | ₹1.30 Cr | ₹1.19 Cr |
Other Long Term Liabilities | ₹1.39 Cr | ₹1.60 Cr |
Long Term Trade Payables | - | - |
Long Term Provisions | ₹0.08 Cr | ₹0.08 Cr |
Total Non-Current Liabilities | ₹77 Cr | ₹62 Cr |
Current Liabilities | - | - |
Trade Payables | ₹26 Cr | ₹47 Cr |
Sundry Creditors | ₹26 Cr | ₹47 Cr |
Acceptances | - | - |
Due to Subsidiaries- Trade Payables | - | - |
Other Current Liabilities | ₹1.65 Cr | ₹3.31 Cr |
Bank Overdraft / Short term credit | - | - |
Advances received from customers | ₹0.08 Cr | ₹0.84 Cr |
Interest Accrued But Not Due | - | - |
Share Application Money | - | - |
Current maturity of Debentures & Bonds | - | - |
Current maturity - Others | - | - |
Other Liabilities | ₹1.57 Cr | ₹2.47 Cr |
Short Term Borrowings | ₹1.39 Cr | - |
Secured ST Loans repayable on Demands | ₹1.39 Cr | - |
Working Capital Loans- Sec | ₹1.39 Cr | - |
Buyers Credits - Unsec | - | - |
Commercial Borrowings- Unsec | - | - |
Other Unsecured Loans | ₹-1.39 Cr | - |
Short Term Provisions | ₹0.12 Cr | ₹0.12 Cr |
Proposed Equity Dividend | - | - |
Provision for Corporate Dividend Tax | - | - |
Provision for Tax | - | - |
Provision for post retirement benefits | - | - |
Preference Dividend | - | - |
Other Provisions | ₹0.12 Cr | ₹0.12 Cr |
Total Current Liabilities | ₹29 Cr | ₹51 Cr |
Total Liabilities | ₹343 Cr | ₹213 Cr |
ASSETS | ||
Gross Block | ₹70 Cr | ₹66 Cr |
Less: Accumulated Depreciation | ₹20 Cr | ₹18 Cr |
Less: Impairment of Assets | - | - |
Net Block | ₹50 Cr | ₹48 Cr |
Lease Adjustment A/c | - | - |
Capital Work in Progress | ₹43 Cr | ₹0.68 Cr |
Non Current Investments | - | - |
Long Term Investment | - | - |
Quoted | - | - |
Unquoted | - | - |
Long Term Loans & Advances | ₹24 Cr | ₹14 Cr |
Other Non Current Assets | - | - |
Total Non-Current Assets | ₹117 Cr | ₹62 Cr |
Current Assets Loans & Advances | - | - |
Currents Investments | ₹38 Cr | ₹34 Cr |
Quoted | ₹38 Cr | ₹34 Cr |
Unquoted | - | - |
Inventories | ₹10 Cr | ₹13 Cr |
Raw Materials | ₹3.66 Cr | ₹7.87 Cr |
Work-in Progress | ₹3.03 Cr | ₹2.06 Cr |
Finished Goods | ₹3.20 Cr | ₹3.03 Cr |
Packing Materials | ₹0.07 Cr | ₹0.02 Cr |
Stores  and Spare | ₹0.06 Cr | ₹0.06 Cr |
Other Inventory | - | - |
Sundry Debtors | ₹46 Cr | ₹89 Cr |
Debtors more than Six months | ₹0.14 Cr | ₹0.22 Cr |
Debtors Others | ₹46 Cr | ₹89 Cr |
Cash and Bank | ₹106 Cr | ₹1.34 Cr |
Cash in hand | ₹12 Cr | ₹1.19 Cr |
Balances at Bank | ₹95 Cr | ₹0.15 Cr |
Other cash and bank balances | - | - |
Other Current Assets | ₹2.02 Cr | ₹1.24 Cr |
Interest accrued on Investments | - | - |
Interest accrued on Debentures | - | - |
Deposits with Government | - | - |
Interest accrued and or due on loans | - | - |
Prepaid Expenses | ₹0.14 Cr | ₹0.52 Cr |
Other current_assets | ₹1.87 Cr | ₹0.72 Cr |
Short Term Loans and Advances | ₹24 Cr | ₹12 Cr |
Advances recoverable in cash or in kind | ₹0.16 Cr | ₹4.02 Cr |
Advance income tax and TDS | ₹4.08 Cr | ₹1.90 Cr |
Amounts due from directors | - | - |
Due From Subsidiaries | - | - |
Inter corporate deposits | - | - |
Corporate Deposits | - | - |
Other Loans & Advances | ₹20 Cr | ₹6.45 Cr |
Total Current Assets | ₹226 Cr | ₹151 Cr |
Net Current Assets (Including Current Investments) | ₹196 Cr | ₹100 Cr |
Miscellaneous Expenses not written off | - | - |
Total Assets | ₹343 Cr | ₹213 Cr |
Contingent Liabilities | ₹17 Cr | ₹0.03 Cr |
Total Debt | ₹76 Cr | ₹59 Cr |
Book Value | 54.51 | 30.86 |
Adjusted Book Value | 54.51 | 30.86 |
Compare Balance Sheet of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹504.8 Cr | -0.6% | 5.1% | -32.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -0.6% |
5.1% |
-32.2% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses